These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 3917651)

  • 21. [Plasma and tissue concentration of tegafur by a new soft capsule type suppository in colorectal carcinoma].
    Namba M; Muto K; Ikeguchi S; Shida S
    Gan To Kagaku Ryoho; 1989 Jan; 16(1):47-52. PubMed ID: 2492183
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [The effect of tegafur suppository and glutathione in patients with gastric and colonic cancer with special reference to the histopathological anticancer effect].
    Kitajima M; Ikeda Y; Kiuchi T; Okada N; Fukuzumi N; Kaga F
    Gan To Kagaku Ryoho; 1987 Nov; 14(11):3131-9. PubMed ID: 3118814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [FT, 5-FU and uracil concentrations of the blood, bile and tissue of hepatoma with liver cirrhosis after oral administration of UFT].
    Oguma S; Sakai K; Sato R; Ouchi K; Owada Y; Sato T
    Gan To Kagaku Ryoho; 1987 Apr; 14(4):1122-8. PubMed ID: 3032114
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Thermotherapy for cancer of the urinary bladder in combination with tegafur suppository and picibanil--concentrations of tegafur in the serum and tissues in bladder carcinoma].
    Murahashi I; Mukae K; Tabata Y; Sakuma H; Kanbe K; Arai T; Kaneko K; Honda M; Maeda S; Takasaki E
    Gan To Kagaku Ryoho; 1985 May; 12(5):1152-5. PubMed ID: 3922314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distributions of tegafur in tissues of gastric adenocarcinoma patients: tissue uptakes and concentrations in plasma after oral and rectal administrations.
    Arima S; Futami K; Yoshimura S; Shimura H
    Jpn J Clin Oncol; 1989 Sep; 19(3):237-41. PubMed ID: 2509764
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Clinical study on concentration of FT-207 and 5-FU in serum, lymph nodes and tissues after rectal administration of FT-207 suppositories for malignant diseases of the liver, biliary tract and pancreas].
    Takada T; Yasuda H; Uchiyama K; Hasegawa H
    Gan To Kagaku Ryoho; 1985 May; 12(5):1088-93. PubMed ID: 3922311
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Study on the concentration of FT-207 and 5-FU in serum and tissues of bladder tumor and prostatic carcinoma].
    Kobayashi H; Sahashi M; Obata K
    Gan To Kagaku Ryoho; 1986 Jun; 13(6):2147-54. PubMed ID: 3087294
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Comparison of continuous venous infusion of 5-FU and FT-207 under total parenteral nutrition].
    Tane S; Ogawa Y; Kido Y; Naruko M; Niwa H; Abe Y; Kobayashi M; Mori T
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):2947-53. PubMed ID: 3094454
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Level of 5-FU in uterine cervical cancer tissue after oral administration of UFT].
    Suzuki M; Sekiguchi I; Ohwada M; Tamada T
    Gan To Kagaku Ryoho; 1985 Nov; 12(11):2139-44. PubMed ID: 3933435
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of two fluorouracil administration regimens for colorectal cancer.
    Matsusaka S; Yamasaki H; Kitayama Y; Okada T; Maeda S
    Oncol Rep; 2003; 10(1):109-13. PubMed ID: 12469154
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1-(2'-tetrahydrofuryl)-5-fluorouracil.
    Ho DH; Pazdur R; Covington W; Brown N; Huo YY; Lassere Y; Kuritani J
    Clin Cancer Res; 1998 Sep; 4(9):2085-8. PubMed ID: 9748123
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Continuous intravenous administration of 1-(2-tetrahydrofuryl)-5-fluorouracil [FT] by intravenous hyperalimentation (IVH)--stability of FT in IVH solution and tumor levels of 5-fluorouracil (5-FU).
    Moriya Y; Koyama Y; Hojo K; Tsunematsu R
    Jpn J Clin Oncol; 1983 Mar; 13(1):31-5. PubMed ID: 6403740
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects on DNA and RNA after the administration of two different schedules of 5-fluorouracil in colorectal cancer patients.
    Hoshino S; Yamashita Y; Maekawa T; Shirakusa T
    Cancer Chemother Pharmacol; 2005 Dec; 56(6):648-52. PubMed ID: 15959779
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [UFT concentration in various tissues from cancer patients].
    Kasai Y; Nakanishi Y; Nishi H; Nishindai H; Yoshimoto M; Nakamura T; Hashimoto I; Sawada Y; Mikami J; Bekki E
    Gan To Kagaku Ryoho; 1983 Oct; 10(10):2130-8. PubMed ID: 6414381
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Determination of 5-FU tissue concentrations after oral UFT administration in tumors of the head and neck].
    Somekawa Y; Asano K; Taira A; Imai R
    Gan To Kagaku Ryoho; 1996 Jan; 23(1):75-9. PubMed ID: 8546473
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Pharmacokinetic studies on fluorinated pyrimidine in cancer cell and tissue].
    Kanamaru R; Wakui A
    Gan To Kagaku Ryoho; 1992 Apr; 19(4):432-8. PubMed ID: 1558391
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Antineoplastic effect of UFT therapy (uracil-FT-207 combination therapy) on experimental pancreatic cancer transplanted in the pancreas and subcutaneous region].
    Ohyama K; Koike D; Odake Y; Takiyama Y; Saitoh T; Kagaya T; Takebe T; Ishii K
    Gan To Kagaku Ryoho; 1982 Dec; 9(12):2168-74. PubMed ID: 6307180
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Serum and tissue concentrations of UFT in patients with lung cancer].
    Aota M; Nakayama S; Yokomise H; Jinno K; Daitoh N
    Gan To Kagaku Ryoho; 1986 Oct; 13(10):3046-55. PubMed ID: 3094458
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Nuclear factor-kappaB activity and its correlation with cell proliferation in non-small cell lung cancer tissues].
    Zhang J; Xu YJ; Zhang ZX; DU CL; Qiao LF; Ni W; Chen SX
    Zhonghua Jie He He Hu Xi Za Zhi; 2007 Oct; 30(10):771-5. PubMed ID: 18218209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Tissue concentration of 5-FU following pre-operative administration of FT-207].
    Sarashina H; Ozaki A; Okamura T; Fukao K; Takase Y; Takeshima T; Todoroki T; Ishikawa A; Orii K; Nagoshi K; Iwasaki Y
    Gan To Kagaku Ryoho; 1982 Jul; 9(7):1277-84. PubMed ID: 6820912
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.